Medicine and Dentistry
Atherosclerosis
100%
Cardiac Magnetic Resonance Imaging
82%
Cardiovascular System
64%
Heart Failure
61%
Gadolinium
59%
Atrial Fibrillation
50%
Cardiovascular Disease
49%
Stenosis
38%
Human Immunodeficiency Virus
38%
Ischemic Heart Disease
30%
Cardiac Fibrosis
30%
Magnetic Resonance Imaging
27%
Fibrosis
25%
Hazard Ratio
24%
Left Ventricle
23%
Myocardium
21%
End-Diastolic Volume
21%
All Cause Mortality
19%
Cardiac Sarcoidosis
19%
Postmenopause
19%
Nonischemic Cardiomyopathy
19%
Fluorodeoxyglucose
19%
Positron Emission Tomography
19%
Fluorine-18
19%
Magnetic Resonance Angiography
19%
Tissue Factor Pathway Inhibitor
19%
Atherectomy
19%
Computer Assisted Tomography
19%
ST Segment Elevation Myocardial Infarction
19%
Hemodynamic
19%
Coronary Angiography
19%
Scintigraphy
19%
Right Ventricle
19%
Stroke Volume
19%
Myocardial Disease
19%
Ejection Fraction
13%
Proportional Hazards Model
11%
Clinical Trial
9%
Brain Natriuretic Peptide
8%
Linear Regression Analysis
6%
Coronary Artery
6%
Diabetes
6%
Body Mass Index
6%
Amino Terminal Sequence
6%
Hormone Precursor
6%
Antiretroviral Therapy
6%
Reproducibility
5%
Study Participant
5%
Keyphrases
Multi-Ethnic Study of Atherosclerosis
76%
Left Atrioventricular Coupling Index
76%
Cardiac Magnetic Resonance Imaging (cMRI)
33%
Heart Failure
32%
Incident Heart Failure
28%
Clinical Outcomes
28%
Atrial Fibrillation
26%
Prognostic Value
26%
Cardiac Fibrosis
25%
T1 Mapping
25%
Cardiovascular Events
21%
Incident Atrial Fibrillation
21%
MESA Study
21%
Ultrashort Echo Time
19%
Clinical Characteristics
19%
Positron Emission Tomography/computerized Tomography
19%
Cardiac Steatosis
19%
Non-contrast
19%
All-cause Mortality
19%
Takotsubo Cardiomyopathy
19%
Intramyocardial
19%
Isolated Cardiac Sarcoidosis
19%
Magnetic Resonance Imaging
19%
Coronary Magnetic Resonance Angiography
19%
Atrial Flutter
19%
Lecithin-cholesterol Acyltransferase
19%
Future Horizons
19%
Recombinant Human
19%
Postmenopausal Women
19%
Fibrosis
19%
Acute ST-segment Elevation Myocardial Infarction
19%
Myocardial Fibrosis
19%
Ventricular Tachycardia
19%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
19%
Infarct Size
19%
Randomized Placebo-controlled Trial
19%
Triglyceride Level
19%
Catheter Coronary Angiography
19%
Metabolic Profiling
19%
Laser Atherectomy
19%
Right Ventricle
19%
Stroke Volume
19%
Left Ventricle
19%
Left Atrial
18%
Hazard Ratio
17%
Cardiovascular Disease
17%
Left Ventricular Function
17%
Late Gadolinium Enhancement
16%
Myocardial Extracellular Volume Fraction
14%
Cardiac Magnetic Resonance
14%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
80%
Heart Failure
67%
Heart Muscle Fibrosis
49%
Cardiovascular Disease
42%
Gadolinium
41%
HIV
38%
Ischemic Heart Disease
30%
Atrial Fibrillation
30%
Fibrosis
24%
Steatosis
24%
Myocardial Disease
22%
Takotsubo Cardiomyopathy
19%
Tissue Factor Pathway Inhibitor
19%
Acp 501
19%
Arrhythmogenesis
19%
Heart Atrium Flutter
19%
ST Segment Elevation Myocardial Infarction
19%
All Cause Mortality
19%
Heart Ventricle Tachycardia
19%
Triacylglycerol
14%
Clinical Trial
7%
Disease
6%
Hormone Precursor
6%
Brain Natriuretic Peptide
6%
N Acetylaspartic Acid
6%
Phosphorylcholine
6%
Heart Atrium Arrhythmia
6%